The effect of antitumor drugs on oxidative stress in B16 and S91 melanoma cells in vitro

Medical Science Monitor

Volumn 11, Issue 1, 2005, Pages

  Woźniak, Alina ^a   Drewa, Gerard ^a   Woźniak, Bartosz ^a   Schachtschabel, Dietrich O ^b   Mila Kierzenkowska, Celestyna ^a   Drewa, Tomasz ^a   Olszewska Słonina, Dorota ^a   Sopońska, Małgorzata ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Fachbereich Medizin der Universitat Marburg   (Germany)

Author keywords

Antitumor drug; Cell culture; Free radicals; Melanoma

Indexed keywords

ALKADIENE; ANTINEOPLASTIC AGENT; BLASTOLEM; CATALASE; CISPLATIN; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VINCRISTINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL STRAIN B16; CELL STRAIN S91; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; IN VITRO STUDY; LIPID PEROXIDATION; MELANOMA CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHASE CONTRAST MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MELANOMA; MICE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 12244305574     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Presant CA, Bartolucci AA: Prognostic factors in metastatic malignant melanoma. Cancer, 1992; 49: 2192-94
2. Borovanský J: Experimental chemotherapy of murine melanomas: Is there a discrepancy compared to clinical experience? Neoplasma, 1997; 44: 277-81
3. Brown CK, Kirkwood JM: Targeted therapy for malignant melanoma. Curr Oncol Rep, 2001; 3: 344-52
4. Trefzer U, Hafmann M, Sterry W, Asdullah K: Cytokine and anticytokine therapy in dermatology. Expert Opin Biol Ther, 2003; 3: 733-43
5. Cvitkovic E: Ongoing and unsaid on oxaliplatin: the hope. Br J Cancer, 1998; 77(Suppl.4): 8-11
6. Halliwell B, Gutteridge JMC: Free Radical in Biology and Medicine. Oxford: Clarendon Press, 1993
7. Bittinger F, Gonzalez-Garcia JL, Klein CL et al: Production of superoxide by human malignant melanoma cells. Melanoma Res, 1998; 8: 381-87
8. Ibrahim HA, El-Meligi AA, Abdel-Hamid M, Elhendy A: Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus. Med Sci Monit, 2004; 10(3): CR85-CR89
9. Abdel-Rahman U, Aybek T, Moritz A et al: Graded reoxygenation limits lipid peroxidation during surgical reperfusion. Med Sci Monit, 2003; 9(9): CR389-CR391
10. Marczuk-Krynicka D, Hryniewiecki T, Pia̧tek J, Paluszak J: The effect of brief food withdrawal on the level of free radicals and other parameters of oxidative status in the liver. Med Sci Minit, 2003; 9(3): BR131-BR135
11. Zachwieja J, Bobkowski W, Dobrowolska-Zachwieja A et al: Decreased andoxidant activity in hypercholesterolemic children with nephrotic syndrome. Med Sci Monit, 2003; 9(6): CR287-CR291
12. Meyskens FL Jr, Farmer P, Fruchauf JP: Redox regulation in human melanocytes and melanoma. Pigment Cell Res, 2001; 14: 148-54
13. Gaudiano G, Koch TH: Redox chemistry of anthracycline antitumor drugs and use of captodative radicals as tools for its elucidation and control. Chem Res Toxicol, 1991; 4: 2-16
14. Sengupta SK, Kelly Ch, Sehgal: "Reverse" and "symmetrical" analogues of actinomycin D: metabolic activation and in vitro and in vivo tumor growth inhibitory activities. J Med Chem, 1985; 28: 620-28
15. Chu G: Cellular responses to cisplatin. The roles of DNA-binding protein and DNA repair. J Biol Chem, 1994; 269: 787-90
16. Roller A, Weller M: Antioxidants specifically inhibit cisplatin cytotoxicity of human malignant glioma cells. Anticancer Res, 1998; 18: 4493-97
17. Thrall BD, Raha GA, Springer DL, Meadows GG: Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Pigment Cell Res, 1991; 4: 234-39
18. Iacobini M, Menichelli A, Palumbo G et al: Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells. Biochem Pharmacol, 2001; 61: 1033-40
19. Hirose M, Fukuzawa K, Kuroda Y: Vincristine resistant HL-60 cells show cross-resistance to hypoxanthine-xanthine oxidase. Cancer Let, 1996; 102: 217-21
20. Olszewska-Słonina D, Drewa T, Musiałkiewicz D, Olszewski K: Comparison of viability of B16 and CI S91 cells in three cytotoxicity tests: cells counting, MTT and flow cytometry after cytostatic drug treatment. Acta Pol Pharm, 2004; 61: 31-37
21. Denizot F, Lang R: Rapid colometric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods, 1986; 89: 271-77
22. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem, 1951; 193: 265-75
23. Buege JA, Aust SD: Microsomal lipid peroxidation. In: Fleisher S, Packer I, editors. Methods in Enzymology. New York: Academic Press; 1978; p. 302-10
24. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In: Packer L, Glazer AN, editor. Methods in Enzymology. New York: Academic Press, 1990; p. 407-21
25. Sergent O, Morel I, Cogrel P et al: Simultaneous measurements of conjugated dienes and free malondialdehyde, used as a micromethod for the evaluation of lipid peroxidation in rat hepatocyte cultures. Chem Phys Lipids, 1993; 65: 133-39
26. Misra HP, Fridovich I: The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem, 1972; 247: 3170-75
27. Beers RF, Seizer JVV: A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem, 1952; 195: 133-40
28. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutatione peroxidase. J Lab Clin Med, 1967; 70: 158-69
29. Taatjes DJ, Fenick DJ, Gaudiano G, Koch TH: A redox pathway leading to the alkylation of nucleic acids by doxorubicin and related anthracyclines: application to the design of antitumor drugs for resistant cancer. Curr Pharm Des, 1998; 4: 203-18
30. Yu BP: Cellular defences against damage from reactive oxygen species. Physiol Rev, 1994; 74: 139-55
31. Longo DL: Principles of cancer therapy. In: Kelley WN, editor. Textbook of Internal Medicine. Philadelphia: JB Lippincott Company; 1989; p. 1219-21
32. Longuet M, Serduc R, Riva C: Implication of bax in apoptosis depends on microtubule network mobility. Int J Oncol, 2004; 25: 309-17
33. Masquelier M, Vitols S: Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside. Biochem Pharmacol, 2004; 67: 1639-46
34. Pervaiz S, Ramalingam JK, Hirpara JL, Clement MV: Superoxide anion inhibits drug-induced tumor cell death. FEBS Lett, 1999; 459: 343-48
35. Aoudjit F, Vuori K: Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells. Oncogene, 2001; 20: 4995-5004
36. Shang X, Shiono Y, Fujita Y et al: Synergistic enhancement of apoptosis by DNA- and cytoskeleton-damaging agents: a basis for combination chemotherapy of cancer. Anticancer Res, 2001; 21(4A): 2585-89
37. Toft NJ, Sansom OJ, Brookes RA et al: In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazine. Carcinogenesis, 2000; 21: 593-98
38. Uslu R, Sanli UA, Sezgin C et al: Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin Cancer Res, 2000; 6: 4957-64
39. Drewa T, Woźniak A, Drewa G et al: Effect of novel platinum complexes on survival rate of B16 and CI S91 melanoma cells and oxidation stress in vitro. Med Sci Monit, 2001; 7: 680-86
40. Bachur NR, Gee MV, Friedman RD: Nuclear catalyzed antibiotic free radical formation. Cancer Res, 1982; 42: 1078-81
41. Yoon SO, Kim MM, Park SJ et al: Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J 2002; 16: 111-13
42. Del Bello B, Valentini MA, Zunino F et al: Cleavage of Bcl-2 in oxidant- and cispiatin- induced apoptosis of human melanoma cells. Oncogene, 2001; 200: 4591-95
43. Bartosz G: Role of reactive oxygen species in apoptosis. Postepy Biochem, 1998; 44: 22-31